| Literature DB >> 26070485 |
Patricia Conde1, Mercedes Rodriguez2, William van der Touw3, Ana Jimenez3, Matthew Burns1, Jennifer Miller3, Manisha Brahmachary4, Hui-ming Chen3, Peter Boros5, Francisco Rausell-Palamos6, Tae Jin Yun7, Paloma Riquelme8, Alberto Rastrojo9, Begoña Aguado9, Joan Stein-Streilein10, Masato Tanaka11, Lan Zhou12, Junfeng Zhang13, Todd L Lowary13, Florent Ginhoux14, Chae Gyu Park15, Cheolho Cheong7, Joshua Brody3, Shannon J Turley16, Sergio A Lira17, Vincenzo Bronte18, Siamon Gordon19, Peter S Heeger1, Miriam Merad3, James Hutchinson8, Shu-Hsia Chen3, Jordi Ochando20.
Abstract
Tissue effector cells of the monocyte lineage can differentiate into different cell types with specific cell function depending on their environment. The phenotype, developmental requirements, and functional mechanisms of immune protective macrophages that mediate the induction of transplantation tolerance remain elusive. Here, we demonstrate that costimulatory blockade favored accumulation of DC-SIGN-expressing macrophages that inhibited CD8(+) T cell immunity and promoted CD4(+)Foxp3(+) Treg cell expansion in numbers. Mechanistically, that simultaneous DC-SIGN engagement by fucosylated ligands and TLR4 signaling was required for production of immunoregulatory IL-10 associated with prolonged allograft survival. Deletion of DC-SIGN-expressing macrophages in vivo, interfering with their CSF1-dependent development, or preventing the DC-SIGN signaling pathway abrogated tolerance. Together, the results provide new insights into the tolerogenic effects of costimulatory blockade and identify DC-SIGN(+) suppressive macrophages as crucial mediators of immunological tolerance with the concomitant therapeutic implications in the clinic.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26070485 PMCID: PMC4690204 DOI: 10.1016/j.immuni.2015.05.009
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745